Navigation Links
Boston Scientific Welcomes Launch of Syntax Score Website
Date:5/18/2009

Online tools will help physicians determine treatment strategies

NATICK, Mass. and BARCELONA, Spain, May 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today welcomed the launch of a new website, www.syntaxscore.com, dedicated to the understanding and use of the SYNTAX Score(TM), a novel angiographic tool used to measure the complexity of coronary artery disease. The Company made the announcement at the annual EuroPCR Scientific Program in Barcelona.

The SYNTAX Score was developed in connection with the SYNTAX trial, the first randomized, controlled clinical trial to compare percutaneous coronary intervention (PCI) using the TAXUS(R) Express2(R) Paclitaxel-Eluting Coronary Stent System to coronary artery bypass graft (CABG) surgery in patients with left main disease and/or significant narrowing of all three coronary arteries (three-vessel disease). These complex patients are traditionally treated with CABG and have been excluded from most prior drug-eluting stent clinical trials. The SYNTAX trial provides important data related to the treatment of these complex patients and should help physicians make more informed treatment decisions.

The SYNTAX Score was used in the trial to characterize coronary anatomy based on nine anatomic criteria, including lesion frequency, complexity and location; it assigned a score to each patient. Higher SYNTAX Scores indicate patients with more complex disease and increased treatment challenges.

The new website allows cardiologists and cardiac surgeons to calculate a patient's SYNTAX Score and create a description of anatomical complexity of the coronary vasculature that can be used in combination with a physician's broader clinical judgment to aid in determining the best revascu
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related biology technology :

1. Fate Therapeutics Granted Exclusive License for Stem Cell Modulators by Childrens Hospital Boston and Massachusetts General Hospital
2. Boston Scientific to Donate Cardiac Rhythm Management Devices to Heartbeat International for Implantation in Needy Patients
3. Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions
4. Xconomy Launches XSITE 2009; First Annual Xconomy Summit on Innovation, Technology, and Entrepreneurship at Boston University
5. UMass Boston Opens Venture Development Center to Expand R&D Activity
6. Boston Scientific Announces First Quarter Special Items
7. Boston Scientific Launches New Coronary Imaging Catheter
8. Moodys Raises Boston Scientifics Rating Outlook to Stable
9. BG Medicine Signs Collaborative Research Agreement with the National Heart, Lung and Blood Institute (NHLBI), and Boston University
10. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual Cowen and Company Healthcare Conference in Boston
11. Boston LASIK Eye Surgery Expert Dr. Peter Rapoza Joins Select Group of Doctors in Trusted LASIK Surgeons Directory

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ay announced a collaborative research agreement wi...luating EpiVax’s proprietary Tregitope techn...immune responses to certain drugs. In the course o...tope technology will be evaluated for its effect o... (Vocus) December 2, 2009 ...
(Date:12/1/2009)...wire-FirstCall/ -- Palatin Technologies, Inc. (NYS...t and Trademark Office has issued U.S. Patent No. ...tructs." The claims in the issued patent cover a ...c peptide receptor A (NPRA), including PL-3994, Pa...Our natriuretic compounds, including PL-3994, addr...
(Date:12/1/2009)...ifornia and AMSTERDAM, December 1 ,...stics, announced today that,Palmetto GBA, Californ...d,coding guidelines for the company,s MammaPrint t...ncer recurrence test, which has been reimbursed by... United States can now submit claims for the,Mamma...
(Date:12/1/2009).... 1 /PRNewswire-Asia-FirstCall/ -- China Sky One M...any") (Nasdaq: CSKI ), a leading,fully integrated...ver-the-counter drugs in the People,s Republic of ...s engaged Guangdong Mediacy Kind Medical Devices,I...clusive sales agent for the,Company,s AMI Diagnost...
Breaking Biology Technology:EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 3Medicare Administrator Establishes Reimbursement Coding Policy for Agendia's Breast Cancer Recurrence Test MammaPrint(R) 2China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 2China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 3
...el Discussion on Technologies That Will Change the...Each Other , , PISCATAWAY, N.J., March 10 IEEE, ..., today spotlighted seven technologies it believes...humans interact with machines, the world and each ... 10 March 2009 at the New Yorker Hotel in New York...
...AI ratio now available with VAP Cholesterol Test a...10 Atherotech, Inc., a cardio-diagnostic company,...(apoAI) to its VAP(R) Cholesterol Test. The VAP (V...esterol test that routinely reports apoAI, apoB, a...of this new marker, the VAP Test now reports apoAI...
...if., March 10 Frost & Sullivan recognizes Bio...p; Sullivan Award for Growth Strategy Leadership o...sis of the most significant drug-discovery innovat... leaders. BioTrove, a privately held company speci...nt technologies, has gained significant traction w...
Other Biology Technology:IEEE Celebrates Its 125th Anniversary Presenting Emerging, World Changing Technologies During Its 'Embracing Human Technology Interactions' Media Event 2IEEE Celebrates Its 125th Anniversary Presenting Emerging, World Changing Technologies During Its 'Embracing Human Technology Interactions' Media Event 3IEEE Celebrates Its 125th Anniversary Presenting Emerging, World Changing Technologies During Its 'Embracing Human Technology Interactions' Media Event 4Atherotech Announces Addition of ApoAI Heart Disease, Diabetes Risk Marker to VAP(R) Test 2Atherotech Announces Addition of ApoAI Heart Disease, Diabetes Risk Marker to VAP(R) Test 3Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies 2Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies 3Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies 4
(Date:11/30/2009)... , , CLEMSON Clemson University researchers Ron ...Environmental Protection Agency grant to study the...ations located deep below the earth,s surface. , ... fuels believed to be the leading cause of global ... most promising alternatives for reducing emission...
(Date:11/30/2009)... , This release is available in German . ,... Collaborative Research Centres as of 1 January 20...t Grants Committee in Bonn. The new centres will i...132 million. In addition, 20 percent overhead fund...ach project. The centres, research topics range fr...
(Date:11/30/2009)... , The Editors of The Journal of Experimental Bi...in from Centre National de la Recherche Scientifiq...s is the winner of this year,s JEB Outstanding P...f an outstanding achievement and is intended to en...e JEB Editor-in-Chief, and adds that ,we truly a...
Breaking Biology News(10 mins):DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 1New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 2New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 3New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 4New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 5New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 6New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 7New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 8New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 9New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 10BIO key 28R 29 International Exhibiting at AABB TXPO 10528 1BIO key 28R 29 International Exhibiting at AABB TXPO 10528 2Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely 60087 1Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely 60087 2Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely 60087 3
... It is well known that animals use song as a way o...t gibbons have developed an unusual way of scaring...ogists at the University of St Andrews discovered ...que song as a natural defence to predators. Liter...se the song not just to warn their own group membe...
... Amsterdam, 21 September, 2006 - Elsevier is delig...ement to the journal Vaccine: HPV Vaccines and Scr...special monograph provides a comprehensive and inv... health educators, policy decision makers, industr...he arrival of the Human Papillomavirus (HPV) vacci...
... Before you request a paternity test, spend a few ... just give you the answer you,re looking for. Acc...versity of Tromso, Norway, the human eye color ref...attern of inheritance. Their studies, published t...y and Sociobiology, show that blue-eyed men find b...
Other Biology News:Singing for survival 2Singing for survival 3Blue eyes -- A clue to paternity 2
...s ideal for developing single and multi-analyte as...m contains the new, improved, and user friendly IS...n specific templates for commercial or home-made m...phing and data regression capabilities; the intern...
GeneSwitch-CHO Cell Line from Invitrogen
...ancements when used as directed, The AmpliCruz ...gned to amplify the desired signal detected by Wes... proteins with low expression., Membrane Enhanc... to blocking the membrane; 1x solution; 250 ml, ...
Silencer CellReady siRNA Transfection Optimization Kit from Ambion
Biology Products: